Artelo Biosciences, Inc. (ARTL) Misses Q1 EPS by 59c

Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q1 EPS of ($0.72), $0.59 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.

You May Also Be Interested In

• Electra Therapeutics files for proposed IPO
• Axis Capital Limited Upgrades Blue Star Limited (BLSTR:IN) to Buy (1)
• Zentek shares to move from Nasdaq to OTC Markets on Sept. 2